Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp ($ADPT), sold about $2.7 million worth of company shares on the open market in seven transactions over the last 365 days. Her most recent sale occurred on March 10, 2026. These sales rank her 2,897th among 11,678 individual insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.45 | 451,540.0000 | 163,162,107 | 4.05% | 0.01% |
| April 2, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 81,719.0000 | 163,162,107 | 15.27% | 0.01% |
| April 1, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 470,600.0000 | 163,162,107 | 3.23% | 0.01% |
| April 1, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 96,441.0000 | 163,162,107 | 13.24% | 0.01% |
| April 2, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.60 | 447,202.0000 | 163,162,107 | 4.09% | 0.01% |
| April 2, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 466,262.0000 | 163,162,107 | 3.26% | 0.01% |
| March 27, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 16322 | $13.48 | 464,554.0000 | 163,162,107 | 3.39% | 0.01% |
| March 27, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 2738 | $12.49 | 480,876.0000 | 163,162,107 | 0.57% | 0.00% |
| March 27, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 483,614.0000 | 163,162,107 | 3.14% | 0.01% |
| March 30, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 125,885.0000 | 163,162,107 | 10.47% | 0.01% |
| March 27, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 140,607.0000 | 163,162,107 | 9.48% | 0.01% |
| March 31, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 111,163.0000 | 163,162,107 | 11.69% | 0.01% |
| March 31, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.45 | 455,878.0000 | 163,162,107 | 4.01% | 0.01% |
| March 31, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 474,938.0000 | 163,162,107 | 3.20% | 0.01% |
| March 30, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $12.63 | 460,216.0000 | 163,162,107 | 3.98% | 0.01% |
| March 30, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 479,276.0000 | 163,162,107 | 3.17% | 0.01% |
| March 25, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 170,051.0000 | 163,162,107 | 7.97% | 0.01% |
| March 26, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 155,329.0000 | 163,162,107 | 8.66% | 0.01% |
| March 24, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 496,628.0000 | 163,162,107 | 3.05% | 0.01% |
| March 24, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.70 | 477,568.0000 | 163,162,107 | 3.84% | 0.01% |
| March 25, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 492,290.0000 | 163,162,107 | 3.08% | 0.01% |
| March 25, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.27 | 473,230.0000 | 163,162,107 | 3.87% | 0.01% |
| March 26, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 487,952.0000 | 163,162,107 | 3.11% | 0.01% |
| March 26, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.12 | 468,892.0000 | 163,162,107 | 3.91% | 0.01% |
| March 24, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 184,773.0000 | 163,162,107 | 7.38% | 0.01% |
| March 23, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 199,495.0000 | 163,162,107 | 6.87% | 0.01% |
| March 20, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 3939 | $6.55 | 494,521.0000 | 163,162,107 | 0.80% | 0.00% |
| March 19, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.18 | 490,582.0000 | 163,162,107 | 3.74% | 0.01% |
| March 19, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 509,642.0000 | 163,162,107 | 2.97% | 0.01% |
| March 20, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 10783 | $7.27 | 505,304.0000 | 163,162,107 | 2.18% | 0.01% |
| March 20, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.37 | 486,244.0000 | 163,162,107 | 3.77% | 0.01% |
| March 23, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $7.27 | 500,966.0000 | 163,162,107 | 3.03% | 0.01% |
| March 23, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.83 | 481,906.0000 | 163,162,107 | 3.80% | 0.01% |
| March 19, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 3,939.0000 | 163,162,107 | 78.89% | 0.01% |
| March 20, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 3939 | $0.00 | 0.0000 | 163,162,107 | 100.00% | 0.00% |
| March 20, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 10783 | $0.00 | 214,217.0000 | 163,162,107 | 4.79% | 0.01% |
| March 16, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 48,105.0000 | 163,162,107 | 23.43% | 0.01% |
| March 16, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 522,656.0000 | 163,162,107 | 2.90% | 0.01% |
| March 16, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.41 | 503,596.0000 | 163,162,107 | 3.65% | 0.01% |
| March 17, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 518,318.0000 | 163,162,107 | 2.92% | 0.01% |
| March 17, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.40 | 499,258.0000 | 163,162,107 | 3.68% | 0.01% |
| March 18, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 513,980.0000 | 163,162,107 | 2.95% | 0.01% |
| March 18, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $13.18 | 494,920.0000 | 163,162,107 | 3.71% | 0.01% |
| March 17, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 33,383.0000 | 163,162,107 | 30.60% | 0.01% |
| March 18, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 18,661.0000 | 163,162,107 | 44.10% | 0.01% |
| March 11, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $14.08 | 516,610.0000 | 163,162,107 | 3.56% | 0.01% |
| March 12, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 531,332.0000 | 163,162,107 | 2.85% | 0.01% |
| March 12, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 13660 | $12.63 | 517,672.0000 | 163,162,107 | 2.57% | 0.01% |
| March 12, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 5400 | $13.43 | 512,272.0000 | 163,162,107 | 1.04% | 0.00% |
| March 13, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 526,994.0000 | 163,162,107 | 2.87% | 0.01% |
| March 13, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19060 | $12.96 | 507,934.0000 | 163,162,107 | 3.62% | 0.01% |
| March 11, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 92,271.0000 | 163,162,107 | 13.76% | 0.01% |
| March 12, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 77,549.0000 | 163,162,107 | 15.96% | 0.01% |
| March 13, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 62,827.0000 | 163,162,107 | 18.98% | 0.01% |
| March 11, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 122523 | $13.17 | 520,948.0000 | 163,162,107 | 19.04% | 0.08% |
| March 11, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 535,670.0000 | 163,162,107 | 2.83% | 0.01% |
| March 6, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 671,207.0000 | 163,162,107 | 2.24% | 0.01% |
| March 6, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $15.14 | 652,147.0000 | 163,162,107 | 4.53% | 0.02% |
| March 9, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 666,869.0000 | 163,162,107 | 2.26% | 0.01% |
| March 9, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 678,750.0000 | 163,162,107 | 1.78% | 0.01% |
| March 9, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $14.79 | 647,809.0000 | 163,162,107 | 4.56% | 0.02% |
| March 10, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 662,531.0000 | 163,162,107 | 2.27% | 0.01% |
| March 10, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 400 | $12.14 | 662,931.0000 | 163,162,107 | 0.06% | 0.00% |
| March 10, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19460 | $14.68 | 643,471.0000 | 163,162,107 | 2.94% | 0.01% |
| March 6, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 136,437.0000 | 163,162,107 | 9.74% | 0.01% |
| March 6, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 415,820.0000 | 163,162,107 | 2.78% | 0.01% |
| March 9, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 121,715.0000 | 163,162,107 | 10.79% | 0.01% |
| March 9, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 403,939.0000 | 163,162,107 | 2.86% | 0.01% |
| March 10, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 106,993.0000 | 163,162,107 | 12.10% | 0.01% |
| March 10, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 400 | $0.00 | 403,539.0000 | 163,162,107 | 0.10% | 0.00% |
| March 6, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 683,088.0000 | 163,162,107 | 1.77% | 0.01% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | A | Common Stock | 81250 | $0.00 | 656,485.0000 | 163,162,107 | 14.12% | 0.05% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 439,582.0000 | 163,162,107 | 2.63% | 0.01% |
| March 5, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 606,176.0000 | 163,162,107 | 2.00% | 0.01% |
| March 5, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $16.00 | 575,235.0000 | 163,162,107 | 5.10% | 0.02% |
| March 3, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 180,603.0000 | 163,162,107 | 7.54% | 0.01% |
| March 3, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 451,463.0000 | 163,162,107 | 2.56% | 0.01% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 165,881.0000 | 163,162,107 | 8.15% | 0.01% |
| March 5, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 594,295.0000 | 163,162,107 | 2.54% | 0.01% |
| March 5, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 14722 | $0.00 | 151,159.0000 | 163,162,107 | 8.88% | 0.01% |
| March 5, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Stock Option (right to buy) | 11881 | $0.00 | 427,701.0000 | 163,162,107 | 2.70% | 0.01% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 30941 | $16.60 | 579,573.0000 | 163,162,107 | 5.07% | 0.02% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 610,514.0000 | 163,162,107 | 1.98% | 0.01% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 598,633.0000 | 163,162,107 | 2.52% | 0.01% |
| March 3, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 6518 | $16.33 | 583,911.0000 | 163,162,107 | 1.10% | 0.00% |
| March 3, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 24423 | $15.49 | 590,429.0000 | 163,162,107 | 3.97% | 0.01% |
| March 3, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 11881 | $12.14 | 614,852.0000 | 163,162,107 | 1.97% | 0.01% |
| March 3, 2026 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | M | Common Stock | 14722 | $6.55 | 602,971.0000 | 163,162,107 | 2.50% | 0.01% |
| March 4, 2025 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | A | Common Stock | 175000 | $0.00 | 647,754.0000 | 147,101,648 | 37.02% | 0.12% |
| March 5, 2025 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 40044 | $6.98 | 607,710.0000 | 147,101,648 | 6.18% | 0.03% |
| March 5, 2025 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President and COO | S | Common Stock | 19461 | $6.99 | 588,249.0000 | 147,101,648 | 3.20% | 0.01% |
| March 5, 2024 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President | S | Common Stock | 13490 | $3.56 | 472,754.0000 | 144,383,294 | 2.77% | 0.01% |
| March 5, 2024 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President | S | Common Stock | 25580 | $3.43 | 486,244.0000 | 144,383,294 | 5.00% | 0.02% |
| March 4, 2024 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President | A | Common Stock | 175000 | $0.00 | 511,824.0000 | 144,383,294 | 51.96% | 0.12% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President | S | Common Stock | 22668 | $8.57 | 336,824.0000 | 142,515,917 | 6.31% | 0.02% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 142,515,917 | 9999.99% | 0.14% |
| March 6, 2023 | Adaptive Biotechnologies Corp | $ADPT | RUBINSTEIN JULIE | President | A | Common Stock | 132979 | $0.00 | 359,492.0000 | 142,515,917 | 58.71% | 0.09% |